Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
Sanofi will buy U.S. vaccines company Dynavax Technologies for around $2.2 billion (1.9 billion euros), the French drugmaker said on Wednesday.
These stocks are expected to see impressive returns while maintaining low volatility, Citi says
Citi highlighted Cboe Global Markets and First Solar as stocks within its positive return on equity trend basket.
Amazon faces ‘leader’s dilemma’ — fight AI shopping bots or join them
Agents like OpenAI’s Instant Checkout and Perplexity’s Instant Buy threaten to reshape the e-commerce landscape.
Motive, an Alphabet-backed fleet management software company, files for IPO
Motive says its products, including a dashboard camera for tracking truckers, have saved over 1,000 lives.
10-year Treasury yield lower as investors mull rates path following strong GDP data
The 10-year benchmark yields edged lower at the start of a shorter trading day.
‘Witch hunt’: Ex-EU commissioner Breton denounces U.S. visa ban targeting ‘censorship’
The former EU commissioner and four anti-disinformation campaigners were the subject of U.S. travel sanctions.
Oil giant BP to sell 65% stake in $10 billion Castrol unit
The oil giant is looking to divest $20 billion of its assets by the end of 2027.
European markets poised for lackluster open ahead of shortened trading session
The Stoxx 600 notched a new record closing high, buoyed by Copenhagen-listed Novo Nordisk.
Japan’s Sapporo Holdings to sell real estate business for $2.6 billion to KKR-led consortium: NHK
The move is because Sapporo wants to concentrate management resources on its core beer business.
Waymo will update driverless fleet after San Francisco blackout to improve navigation during outages
Three days after blackouts in San Francisco brought down Waymo’s service, the company said it’s implementing changes for when “infrastructure fails.”